Salim Souid, MD
Pediatrics · Brooklyn, NYNPI 1689869067
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Collegium Pharmaceutical, Inc. at 28.1% of the total. 2025 is the largest year on record at $258, 7.4 times the $35 reported in 2022.
Across 20 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$109
- Pfizer$83
- Tris Pharma Inc$65
- Vertical Pharmaceuticals, LLC$51
- Novo Nordisk$28
- Sanofi$21
- plus $29 from 2 others
What the payments were for
- Food & beverage$387100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 5 | $109 |
| Pfizer | 4 | $83 |
| Tris Pharma Inc | 4 | $65 |
| Vertical Pharmaceuticals, LLC | 3 | $51 |
| Novo Nordisk | 1 | $28 |
| Sanofi | 1 | $21 |
| Cranial Technologies, Inc | 1 | $15 |
| Phadia US Inc. | 1 | $14 |
How this compares
$387 in reported general payments places this provider in the 65th percentile of 4,055 pediatrics providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 18 | $21,958 |
| MounjaroTirzepatide | 17 | $18,393 |
| MeloxicamMeloxicam, Submicronized | 18 | $11,095 |
| Chlorzoxazone | 18 | $9,953 |
| Diclofenac Sodium | 22 | $9,578 |
| Diclofenac Epolamine | 29 | $9,421 |
| Diflorasone Diacetate | 15 | $7,254 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 38 | $1,329 |
| Atorvastatin Calcium | 72 | $330 |
| Cyclobenzaprine Hcl | 15 | $297 |
| Alcohol Prep PadsAlcohol Antiseptic Pads | 26 | $204 |
| Amlodipine Besylate | 54 | $196 |
| Nifedipine ErNifedipine | 11 | $195 |
| Omeprazole | 19 | $177 |
| Montelukast Sodium | 26 | $148 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Brooklyn
- Patrick SchnellBrooklyn$164K
- Warren SeigelBrooklyn$162K
- Steven SchwarzBrooklyn$28K
- Sherry SakowitzBrooklyn$27K
- Howard LevineBrooklyn$24K
- Jimmy SittBrooklyn$10K
- Marina GoldisBrooklyn$9K
- Han ZhangBrooklyn$7K
- Philip OzuahBronx$1M
- Michael PichicheroRochester$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.